Nebraska Legislature - Lobbyist Reporting Application

Clerk of the Legislature

Room 2014 State Capitol

PO Box 94604

Lincoln, NE 68509

(402) 471-2608

NEBRASKA LOBBYIST
STATEMENT of ACTIVITY

NADC FORM D

Submission Date: May 28, 2026

Each registered lobbyist shall file a Statement of Activity within 45 days after the end of a regular session of the Legislature. The statement must be filed even if the lobbyist engaged in no activity.
Any registered lobbyist who engages in lobbying activity in connection with a special session of the Legislature shall file a Statement of Activity within 45 days after the end of the special session. Late filing fees are $25.00 per day, not to exceed $750.00.
Lobbyists having more than one principal shall file a separate report for each principal.

ITEM 1

NATURE OF FILING (Check appropriate box)

For Calendar Year of

2026

Regular Session

Special Session

Amended Report

ITEM 2

NAME OF LOBBYIST AND PRINCIPAL

LOBBYIST

Lobbyist Name

Mueller Robak

Phone

(402) 434-3399

Address

530 S. 13th Street, Suite 110

City

Lincoln

State

Zip

68508

PRINCIPAL

Principal Name

Pharmaceutical Research and Manufacturers of America

Office Phone

(202) 835-3547

Office Address (Street, Box, or Route)

670 Maine Ave SW, Suite 1000

City

Washington

State

Zip

20024

List all the legislation upon which the lobbyist acted on behalf of the principal including bills, resolutions, amendments and procedural matters. Identify by number of bill, resolution, amendment or procedural matter and state the position taken. This statement should include a list of amendments or procedural matters which the lobbyist has acted upon for the principal, even if the lobbyist has not acted upon the bill or resolution from which the amendment or procedural matter arises.

Identify bill or resolution number	Describe bill, resolution, amendment or procedural matter	Position taken
LB109	Prohibit certain provisions in insurance policies and health plans relating to clinician-administered drugs and change provisions relating to pharmacy benefit managers	Neutral
LB158	Provide requirements for health carriers or pharmacy benefit managers regarding out-of-pocket maximums and cost-sharing requirements	Support
LB253	Provide for insurance and medicaid coverage of biomarker testing	Neutral
LB310	Provide an exemption from newborn screening for certain diseases or conditions	Neutral
LB533	Provide requirements relating to clinician-administered drugs under the Pharmacy Benefit Manager Licensure and Regulation Act	Neutral
LB723	Provide for implementation of community engagement requirements under the Medical Assistance Act	Neutral
LB762	Require insurance coverage of pediatric autoimmune disorders	Neutral
LB774	Create the Rural Health Transformation Program Fund to be administered by the Department of Health and Human Services	Neutral
LB775	Create the Rural Health Transformation Program within the Department of Health and Human Services	Neutral
LB858	Appropriate funds to the Department of Health and Human Services for federally qualified community health centers	Neutral
LB867	Change provisions relating to special needs trusts, fingerprints under the Uniform Credentialing Act, child care grants, the Title IV-D Division Customer Service Unit, eligibility for young adults in the bridge to independence program, licensed and self-funded insurers under the Medical Assistance Act, medicaid nursing facility rates, assistance to aged, blind, or disabled persons, and the state Commodity Supplemental Food program; provide for a money follows the person program for medicaid benefits, a youth afterschool eligibility letter for child care employment, use of wholesale drug distributor license fees for the prescription drug monitoring program, and maintenance of epinephrine by certain schools; change provisions of and rename the Alzheimer's Disease and Other Dementia Support Act , the Alzheimer's Disease and Other Dementia Advisory Council, the State Advisory Committee on Mental Health, the Division of Developmental Disabilities of the Department of Health and Human Services, and the Director of Developmental Disabilities; and eliminate provisions relating to divisions of the Department of Health and Human Services, the Division of Medicaid and Long-Term Care Advisory Committee on Aging, the Maternal and Child Health and Public Health Work Fund, and an obsolete Nurse Licensure Compact	Neutral
LB967	Change provisions relating to insurance fees, licensing, and trade practices, pharmacy benefit managers, mutual insurance holding companies, the Population Health Information Act, the Health Information Technology Board, and the Site and Building Development Act and adopt the Nebraska Protection of Seniors from Insurance Exploitation Act	Neutral
LB1043	Include prescription antidepressants, antipsychotics, and anticonvulsants on the preferred drug list under the Medical Assistance Act	Neutral
LB1062	Change provisions relating to the Insurance Producers Licensing Act and the Pharmacy Benefit Manager Licensure and Regulation Act	Neutral
LB1071	Provide, change, and eliminate provisions related to appropriations for the expenses of Nebraska State Government for the biennium ending June 30, 2027	Neutral
LB1072	Provide for and change transfers from the Cash Reserve Fund and provide, change, and eliminate provisions relating to fees, funds, fund transfers, agency powers and duties, and various statutory programs	Neutral
LB1132	Require the Department of Health and Human Services to file a state plan amendment for coverage of long-acting injectable and extended-release medications for certain individuals	Neutral
LB1144	Redefine a term and provide requirements for entities issuing health plans under the Medical Assistance Act	Neutral
LB1222	Require insurance coverage of acquired brain injury services and require insurance and medicaid coverage of certain testing and treatments for Alzheimer's disease and related dementia	Neutral
LB1229	Create the Rural Health Transformation Fund	Neutral

I certify that all information presented in this form is accurate to the best of my knowledge.

Mueller Robak LLC

Lobbyist Name

May 28, 2026

Date